1[1]Janerich DT,Lawrence CE,Jacobson HI.Fertility patterns after discontinuation of use oral contraceptives.Lancet,1976,1:1051-1053.
2[2]Fukuda M,Katayama K,Tojo S.Inhibitory effect of progesterone on follicular growth and induced superovulation in the rat.Arch Gynecol,1980,230:77-78.
3[3]Branigan EF,Estes MA.Treatment of chronic anovulation resistant to clomiphene citrate treatment.Am J Obstet Gynecol,2003,188:1424-1428.
4[4]Templeton A,van Look P,Lumsden MA,et al.The recovery of pre-ovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration.Br J Obstet Gynecol,1984,91:148-154.
5[5]Biljan MM,Mahutte NG,Dean N,et al.Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation analogues.J Assist Reorod Genet,1998,15:599-604.
6[6]Biljan MM,Mahutte NG,Dean N,et al.Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.Fertil Steril,1998,70:1063-1069.
7[7]Damario MA,Barmat L,Liu HC,et al.Suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in vitro fertilization outcome in high responder patients.Hum Reprod,1997,12:2359-2365.
8[8]Lindheim SR,Barad DH,Witt B,et al.Short term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.J Assist Reprod Genet,1996,13:745-747.
9[9]Duvan CI,Berker B,Turhan NO,et al.Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients.J Assist Reprod Genet,2008,25:89-93.
10[10]Copperman AB.Antagonists in poor-responder patients.Fertil Steril,2003,80:16-24.
